Efficacy and tolerability of agomelatine in generalized anxiety disorder (gad) : A randomised double-blind, placebo-controlled trial with escitalopram as validator

被引：0
|
作者：
Stein, D. [1 ]
Marquez, M. S. [1 ]
Hoeschl, C. [1 ]
Ahokas, A. [1 ]
Oh, K. S. [1 ]
Jarema, M. [1 ]
Avedisova, A. [1 ]
Vavrusova, L. [1 ]
Olivier, V. [1 ]
机构：
[1] Univ Cape Town, Dept Psychiat, Cape Town, South Africa
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-04-019
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [21] Preliminary results evaluating cognitive function in elderly from double-blind, placebo-controlled trial of pregabalin in generalized anxiety disorder (gad)
    Carrasco, M. M.
    Baldinetti, F.
    Leon, T.
    Mandel, F.
    Pauer, L.
    Chatamra, K.
    EUROPEAN PSYCHIATRY, 2007, 22 : S279 - S280
  • [22] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
  • [23] Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial
    Linder, Steven L.
    Mathew, Ninan T.
    Cady, Roger K.
    Finlayson, Gary
    Ishkanian, Gary
    Lewis, Donald W.
    HEADACHE, 2008, 48 (09): : 1326 - 1336
  • [24] Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study
    Rickels, K
    Zaninelli, R
    McCafferty, J
    Bellew, K
    Iyengar, M
    Sheehan, D
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 749 - 756
  • [25] Tiagabine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study
    Pollack, M
    Van Ameringen, M
    Snyder, H
    Brown, C
    Ondrasik, J
    Roy-Byrne, P
    Rickels, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S538 - S538
  • [26] Adjunctive risperidone in generalized anxiety disorder: A double-blind, placebo-controlled study
    Brawman-Mintzer, O
    Knapp, RG
    Nietert, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1321 - 1325
  • [27] A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan
    Asakura, Satoshi
    Hayano, Taiji
    Hagino, Atsushi
    Koyama, Tsukasa
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 749 - 757
  • [28] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder
    Montgomery, SA
    Nil, R
    Dürr-Pal, N
    Loft, H
    Boulenger, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278
  • [29] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF KETAZOLAM IN ANXIETY
    BOWDEN, CL
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1978, 24 (02): : 170 - 178
  • [30] Efficacy of sertraline in severe generalized social anxiety disorder: Results of a double-blind, placebo-controlled study
    Liebowitz, MR
    DeMartinis, NA
    Weihs, K
    Londborg, PD
    Smith, WT
    Chung, H
    Fayyad, R
    Clary, CM
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (07) : 785 - 792
12345